Wuhan United Pharmaceutical

Wuhan United Pharmaceutical is a Chinese pharmaceutical manufacturer focused primarily on modernized traditional Chinese medicines and related healthcare products. Founded in 1998 and based in Wuhan, the company operates a GMP-certified production base and conducts in-house research, development, and commercialization of prescription drugs, APIs, health products, and extract-based medicines. Its flagship product is Shengxue Ning Tablets, a marketed Chinese medicine for anemia that has been highlighted by the company as a core commercial asset. The company also has historical development work in products such as valerian extract capsules and other Chinese medicine formulations. Overall, it appears to be a commercial-stage regional pharma company centered on manufacturing and modern TCM product development rather than a venture-backed innovative biotech pipeline company.